AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 104 filers reported holding AKERO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,178,024 | -58.8% | 102,420 | -61.9% | 0.00% | -50.0% |
| Q2 2023 | $12,553,685 | +15.7% | 268,917 | -5.1% | 0.00% | 0.0% |
| Q1 2023 | $10,846,863 | +68012.2% | 283,516 | -2.4% | 0.00% | -20.0% |
| Q4 2022 | $15,925 | -99.8% | 290,606 | -0.3% | 0.01% | +25.0% |
| Q3 2022 | $9,917,000 | +189.8% | 291,391 | -19.5% | 0.00% | +300.0% |
| Q2 2022 | $3,422,000 | -28.6% | 361,988 | +7.2% | 0.00% | 0.0% |
| Q1 2022 | $4,794,000 | -10.2% | 337,790 | +33.9% | 0.00% | -50.0% |
| Q4 2021 | $5,336,000 | +13.6% | 252,265 | +20.0% | 0.00% | 0.0% |
| Q3 2021 | $4,699,000 | -11.9% | 210,246 | -2.2% | 0.00% | 0.0% |
| Q2 2021 | $5,336,000 | +462.9% | 215,062 | +557.8% | 0.00% | – |
| Q1 2021 | $948,000 | -25.5% | 32,694 | -33.7% | 0.00% | – |
| Q4 2020 | $1,273,000 | – | 49,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
| COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
| Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
| Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
| Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
| Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
| Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
| Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |